| Literature DB >> 32292963 |
Sven Epple1, Cameron Thorpe1, Ysobel R Baker1, Afaf H El-Sagheer2, Tom Brown1.
Abstract
Antisense oligonucleotides are now entering the clinic for hard-to-treat diseases. New chemical modifications are urgently required to enhance their drug-like properties. We combine amide coupling with standard oligonucleotide synthesis to assemble backbone chimera gapmers that trigger an efficient RNase H response while improving serum life time and cellular uptake.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32292963 DOI: 10.1039/d0cc00444h
Source DB: PubMed Journal: Chem Commun (Camb) ISSN: 1359-7345 Impact factor: 6.222